A Prospective Randomized Trial of Prostate Biopsy Protocols Comparing the Vienna Nomogram and a Standard 10-core Biopsy Scheme
Primary Purpose
Prostate Cancer
Status
Completed
Phase
Not Applicable
Locations
Portugal
Study Type
Interventional
Intervention
10-core prostate biopsy protocol
Vienna nomogram prostate biopsy protocol
Sponsored by
About this trial
This is an interventional diagnostic trial for Prostate Cancer focused on measuring Prostate cancer, Prostate biopsy, Vienna nomogram
Eligibility Criteria
Inclusion Criteria:
- PSA elevation
- Abnormal digital rectal examination
- Abnormal findings on prostate imaging
Exclusion Criteria:
- Active urinary tract infection
- Documented previous pathological prostatitis
- History of urinary retention
- Recent lower urinary tract surgery
Sites / Locations
- Urology Department - Hospital de Santa Maria
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Active Comparator
Arm Label
10-core prostate biopsy protocol group
Vienna nomogram prostate biopsy protocol group
Arm Description
Ultrasound guided prostate biopsy with extraction of 10 cores
Ultrasound guided prostate biopsy performed according to the Vienna nomogram
Outcomes
Primary Outcome Measures
Prostate cancer detection rate
Secondary Outcome Measures
Prostate cancer detection rate in prostate volume and age subclasses
Gleason score concordance between biopsy and prostatectomy specimens
Full Information
NCT ID
NCT01752140
First Posted
December 13, 2012
Last Updated
December 15, 2012
Sponsor
Hospital de Santa Maria, Portugal
1. Study Identification
Unique Protocol Identification Number
NCT01752140
Brief Title
A Prospective Randomized Trial of Prostate Biopsy Protocols Comparing the Vienna Nomogram and a Standard 10-core Biopsy Scheme
Official Title
A Prospective Randomized Trial of Prostate Biopsy Protocols Comparing the Vienna Nomogram and a Standard 10-core Biopsy Scheme
Study Type
Interventional
2. Study Status
Record Verification Date
December 2012
Overall Recruitment Status
Completed
Study Start Date
January 2009 (undefined)
Primary Completion Date
July 2010 (Actual)
Study Completion Date
July 2010 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Hospital de Santa Maria, Portugal
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
In this study, the investigators aim to determine if the Vienna nomogram increases the detection rate of TRUS-guided prostate biopsies by conducting a prospective randomized study comparing the Vienna nomogram with a 10-core biopsy protocol.
Detailed Description
Trans rectal ultrasound (TRUS) guided prostate biopsy remains the standard for prostate cancer diagnosis. However, the standard protocols miss 15 to 30% of cancers, leading to a variable number of repeat biopsies.
In 2005 the Vienna nomogram was introduced, defining the number of cores to be obtained in a prostate biopsy in relation to age and prostate volume in patients with a serum PSA level of 2-10 ng/mL.
The objective of the study is to determine if the Vienna nomogram increases the detection rate of trans rectal ultrasound guided prostate biopsies, compared to a 10-core biopsy.
This prospective randomized study enrolled men eligible for a prostate biopsy were randomized to a Vienna nomogram protocol or a 10-core protocol. They were further stratified according to age (≤65; >65 and ≤70; >70 years) and prostate volume (≤30; >30 and ≤50; >50 and ≤70; >70 cc).
A subgroup analysis for patients with serum PSA values between 2 and 10 ng/mL was performed.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Prostate Cancer
Keywords
Prostate cancer, Prostate biopsy, Vienna nomogram
7. Study Design
Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
463 (Actual)
8. Arms, Groups, and Interventions
Arm Title
10-core prostate biopsy protocol group
Arm Type
Active Comparator
Arm Description
Ultrasound guided prostate biopsy with extraction of 10 cores
Arm Title
Vienna nomogram prostate biopsy protocol group
Arm Type
Active Comparator
Arm Description
Ultrasound guided prostate biopsy performed according to the Vienna nomogram
Intervention Type
Procedure
Intervention Name(s)
10-core prostate biopsy protocol
Intervention Description
Local vascular bundle anesthesia with 2% lidocaine was performed using a 22G Chiba needle. Ultrasound guided prostate biopsy using a standard biopsy device to obtain 10 biopsy cores.
Intervention Type
Procedure
Intervention Name(s)
Vienna nomogram prostate biopsy protocol
Intervention Description
Local vascular bundle anesthesia with 2% lidocaine was performed using a 22G Chiba needle. Ultrasound guided prostate biopsy using a standard biopsy device to obtain a number of cores as defined by the Vienna nomogram.
Primary Outcome Measure Information:
Title
Prostate cancer detection rate
Time Frame
Up to four weeks after intervention
Secondary Outcome Measure Information:
Title
Prostate cancer detection rate in prostate volume and age subclasses
Time Frame
Up to four weeks after intervention
Title
Gleason score concordance between biopsy and prostatectomy specimens
Time Frame
Up to four weeks after prostatectomy
10. Eligibility
Sex
Male
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
PSA elevation
Abnormal digital rectal examination
Abnormal findings on prostate imaging
Exclusion Criteria:
Active urinary tract infection
Documented previous pathological prostatitis
History of urinary retention
Recent lower urinary tract surgery
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Tito P Leitão, Dr.
Organizational Affiliation
Hospital de Santa Maria
Official's Role
Principal Investigator
Facility Information:
Facility Name
Urology Department - Hospital de Santa Maria
City
Lisboa
State/Province
Lisbon
ZIP/Postal Code
1649-035
Country
Portugal
12. IPD Sharing Statement
Citations:
PubMed Identifier
7502425
Citation
Uzzo RG, Wei JT, Waldbaum RS, Perlmutter AP, Byrne JC, Vaughan ED Jr. The influence of prostate size on cancer detection. Urology. 1995 Dec;46(6):831-6. doi: 10.1016/s0090-4295(99)80353-7.
Results Reference
background
PubMed Identifier
17342490
Citation
Djavan B, Margreiter M. Biopsy standards for detection of prostate cancer. World J Urol. 2007 Mar;25(1):11-7. doi: 10.1007/s00345-007-0151-1. Epub 2007 Mar 7.
Results Reference
background
PubMed Identifier
21087452
Citation
Lecuona A, Heyns CF. A prospective, randomized trial comparing the Vienna nomogram to an eight-core prostate biopsy protocol. BJU Int. 2011 Jul;108(2):204-8. doi: 10.1111/j.1464-410X.2010.09887.x. Epub 2010 Nov 19.
Results Reference
background
PubMed Identifier
16145388
Citation
Remzi M, Fong YK, Dobrovits M, Anagnostou T, Seitz C, Waldert M, Harik M, Marihart S, Marberger M, Djavan B. The Vienna nomogram: validation of a novel biopsy strategy defining the optimal number of cores based on patient age and total prostate volume. J Urol. 2005 Oct;174(4 Pt 1):1256-60; discussion 1260-1; author reply 1261. doi: 10.1097/01.ju.0000173924.83392.cc.
Results Reference
background
Learn more about this trial
A Prospective Randomized Trial of Prostate Biopsy Protocols Comparing the Vienna Nomogram and a Standard 10-core Biopsy Scheme
We'll reach out to this number within 24 hrs